small molecule

HALFLYTELY

BISACODYL; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE

Loss of exclusivity—loss of exclusivity

CompanyBraintree →See this company's full patent-cliff portfolio

Drug detail

Brand name	HALFLYTELY
Active ingredient	BISACODYL; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE
Strength	5MG,N/A;N/A,210GM;N/A,0.74GM;N/A,2.86GM;N/A,5.6GM Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons
Dosage form	FOR SOLUTION, TABLET, DELAYED RELEASE
Route	ORAL
Modality	Small molecule
FDA approval	July 2010
Marketing status	DISCN

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.